In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in
2007/08 will reach the age (25 years) for cervical cancer (CC) screening from 2017. The …

Background Several countries have implemented vaccination against human papillomavirus
(HPV) for adolescent girls and must decide whether and how to adapt cervical cancer (CC) …

The EUROGIN 2010 roadmap represents a continuing effort to provide and interpret
updated information on cervical cancer screening and vaccination against the cause of the …

Screening for, and treatment of, pre-cancerous cervical lesions has lead to dramatic
reductions in cervical cancer in many countries. In all cases, cervical screening has been …

Cervical cancer is relatively rare in high‐income countries, where organized screening
programs are in place, as well as opportunistic ones. As the human papillomavirus (HPV) …

Objective To assess the effectiveness of an HPV vaccination programme in reducing the risk
of cervical abnormalities identified at subsequent screening. Design Retrospective cohort …

Background: Current US cervical cancer screening guidelines do not differentiate
recommendations based on a woman's human papillomavirus (HPV) vaccination status …

Human Papillomavirus (HPV) vaccines will likely have an impact as a preventive strategy for
cervical cancer. Screening for precancerous lesions cannot be discontinued because …

More than ever, clinicians need regularly updated reviews given the continuously increasing
amount of new information regarding innovative cervical cancer prevention methods. A …

Women vaccinated against HPV16/18 are approaching the age for cervical screening;
however, an updated screening algorithm has not been agreed. We use a microsimulation …